Literature DB >> 16271362

A high-efficiency system of natural killer cell cloning.

Rebecca J Morris1, Lee K Chong, Gavin W G Wilkinson, Eddie C Y Wang.   

Abstract

The culture of human natural killer (NK) cell clones has traditionally been a long, laborious process with an efficiency of only 1-2%. Recently, a stem cell growth medium (SCGM) has been described to expand preferentially polyclonal NK cells from peripheral blood. We have tested SCGM in a single cell sorting system and shown a 4-5 fold increase in the number of proliferating NK clones compared to standard RPMI media. The cloning efficiency was further enhanced by the provision of irradiated feeder cells derived from multiple donors combined with the addition of the anti-CD3 antibody, OKT3. The combination of SCGM, single cell sorting and these multiple optimisations enhanced NK cloning efficiency by more than tenfold to greater than 20% for short-term cultures when deriving 10(5) cells and as high as 10% for longer term cultures when deriving more than 2 x 10(6) cells. This novel system thus facilitates the generation of NK clones and allows larger scale studies of NK function that were beyond the scope of previous methodology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271362      PMCID: PMC2843082          DOI: 10.1016/j.jim.2005.08.015

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  37 in total

1.  Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution.

Authors:  S Carlens; M Gilljam; M Remberger; J Aschan; B Christensson; M S Dilber
Journal:  Exp Hematol       Date:  2000-10       Impact factor: 3.084

2.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Authors:  V M Braud; D S Allan; C A O'Callaghan; K Söderström; A D'Andrea; G S Ogg; S Lazetic; N T Young; J I Bell; J H Phillips; L L Lanier; A J McMichael
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

3.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones.

Authors:  H Yssel; J E De Vries; M Koken; W Van Blitterswijk; H Spits
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

4.  Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells.

Authors:  S D Lyman; L James; L Johnson; K Brasel; P de Vries; S S Escobar; H Downey; R R Splett; M P Beckmann; H J McKenna
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

5.  The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction.

Authors:  E M Bluman; G S Schnier; B R Avalos; M P Strout; H Sultan; F W Jacobson; D E Williams; W E Carson; M A Caligiuri
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

6.  A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.

Authors:  S Carlens; M Gilljam; B J Chambers; J Aschan; H Guven; H G Ljunggren; B Christensson; M S Dilber
Journal:  Hum Immunol       Date:  2001-10       Impact factor: 2.850

7.  Cloning of Human T and Natural Killer Cells

Authors: 
Journal:  Methods       Date:  1996-06       Impact factor: 3.608

Review 8.  Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex.

Authors:  M K Kennedy; L S Park
Journal:  J Clin Immunol       Date:  1996-05       Impact factor: 8.317

9.  Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.

Authors:  Peter Tomasec; Eddie C Y Wang; Andrew J Davison; Borivoj Vojtesek; Melanie Armstrong; Cora Griffin; Brian P McSharry; Rebecca J Morris; Sian Llewellyn-Lacey; Carole Rickards; Akio Nomoto; Christian Sinzger; Gavin W G Wilkinson
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Developmental and Functional Control of Natural Killer Cells by Cytokines.

Authors:  Yang Wu; Zhigang Tian; Haiming Wei
Journal:  Front Immunol       Date:  2017-08-04       Impact factor: 7.561

2.  Adenovirus vector delivery stimulates natural killer cell recognition.

Authors:  Peter Tomasec; Eddie C Y Wang; Veronika Groh; Thomas Spies; Brian P McSharry; Rebecca J Aicheler; Richard J Stanton; Gavin W G Wilkinson
Journal:  J Gen Virol       Date:  2007-04       Impact factor: 3.891

3.  The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.

Authors:  Isabel Y Pappworth; Eddie C Wang; Martin Rowe
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

4.  The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.

Authors:  Virginie Prod'homme; Cora Griffin; Rebecca J Aicheler; Eddie C Y Wang; Brian P McSharry; Carole R Rickards; Richard J Stanton; Leszek K Borysiewicz; Miguel López-Botet; Gavin W G Wilkinson; Peter Tomasec
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

5.  Cattle NK Cell Heterogeneity and the Influence of MHC Class I.

Authors:  Alasdair J Allan; Nicholas D Sanderson; Simon Gubbins; Shirley A Ellis; John A Hammond
Journal:  J Immunol       Date:  2015-07-27       Impact factor: 5.422

6.  HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells.

Authors:  Richard J Stanton; Virginie Prod'homme; Marco A Purbhoo; Melanie Moore; Rebecca J Aicheler; Marcus Heinzmann; Susanne M Bailer; Jürgen Haas; Robin Antrobus; Michael P Weekes; Paul J Lehner; Borivoj Vojtesek; Kelly L Miners; Stephen Man; Gavin S Wilkie; Andrew J Davison; Eddie C Y Wang; Peter Tomasec; Gavin W G Wilkinson
Journal:  Cell Host Microbe       Date:  2014-08-13       Impact factor: 21.023

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.